Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients

Atypical femur fractures (AFFs), considered rare associations of bisphosphonates, have also been reported in patients with monogenic bone disorders without bisphosphonate use. The exact association between AFFs and monogenic bone disorders remains unknown. Our aim was to determine the prevalence of monogenic bone disorders in a Dutch AFF cohort. AFF patients were recruited from two specialist bone centers in the Netherlands. Medical records of the AFF patients were reviewed for clinical features of monogenic bone disorders. Genetic variants identified by whole-exome sequencing in 37 candidate genes involved in monogenic bone disorders were classified based on the American College of Medical Genetics and Genomics (ACMG) classification guidelines. Copy number variations overlapping the candidate genes were also evaluated using DNA array genotyping data. The cohort comprises 60 AFF patients (including a pair of siblings), with 95% having received bisphosphonates. Fifteen AFF patients (25%) had clinical features of monogenic bone disorders. Eight of them (54%), including the pair of siblings, had a (likely) pathogenic variant in either PLS3, COL1A2, LRP5, or ALPL. One patient carried a likely pathogenic variant in TCIRG1 among patients not suspected of monogenic bone disorders (2%). In total, nine patients in this AFF cohort (15%) had a (likely) pathogenic variant. In one patient, we identified a 12.7 Mb deletion in chromosome 6, encompassing TENT5A. The findings indicate a strong relationship between AFFs and monogenic bone disorders, particularly osteogenesis imperfecta and hypophosphatasia, but mainly in individuals with symptoms of these disorders. The high yield of (likely) pathogenic variants in AFF patients with a clinical suspicion of these disorders stresses the importance of careful clinical evaluation of AFF patients. Although the relevance of bisphosphonate use in this relationship is currently unclear, clinicians should consider these findings in medical management of these patients. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

[1]  S. Mundlos,et al.  Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders , 2022, The Journal of clinical endocrinology and metabolism.

[2]  Y. Uesawa,et al.  Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database , 2021, Pharmaceuticals.

[3]  Valentina Capo,et al.  Autosomal recessive osteopetrosis: mechanisms and treatments , 2021, Disease models & mechanisms.

[4]  A. Verkerk,et al.  The Genetics of Atypical Femur Fractures—a Systematic Review , 2021, Current Osteoporosis Reports.

[5]  W. Högler,et al.  Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis , 2021, International journal of molecular sciences.

[6]  K. Byth,et al.  The Sydney AFF Score: A Simple Tool to Distinguish Females Presenting With Atypical Femur Fractures Versus Typical Femur Fractures , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  O. Mäkitie,et al.  Early-Onset Osteoporosis , 2015, Calcified Tissue International.

[8]  S. Mundlos,et al.  Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early‐Onset Osteoporosis (EOOP) , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  Alexander E. Lopez,et al.  Exome sequencing and characterization of 49,960 individuals in the UK Biobank , 2020, Nature.

[10]  Erik J. Geiger,et al.  Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. , 2020, The New England journal of medicine.

[11]  A. Uitterlinden,et al.  Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time , 2020, Genetics in Medicine.

[12]  P. Schneider,et al.  Osteogenesis imperfecta: towards an individualised interdisciplinary care strategy to improve physical activity and quality of life. , 2020, Swiss medical weekly.

[13]  C. Shore-Lorenti,et al.  Asian ethnicity is associated with atypical femur fractures in an Australian population study. , 2020, Bone.

[14]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[15]  S. South,et al.  Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) , 2019, Genetics in Medicine.

[16]  W. Reardon,et al.  COL1‐related overlap disorder: A novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers‐Danlos syndrome overlap , 2019, Clinical genetics.

[17]  R. Finkel,et al.  Dominant collagen XII mutations cause a distal myopathy , 2019, Annals of clinical and translational neurology.

[18]  F. Rauch,et al.  Mendelian bone fragility disorders. , 2019, Bone.

[19]  M. Bouxsein,et al.  Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management. , 2019, Endocrine reviews.

[20]  S. Kõks,et al.  De novo and inherited pathogenic variants in collagen‐related osteogenesis imperfecta , 2019, Molecular genetics & genomic medicine.

[21]  N. Guañabens,et al.  Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures , 2018, JBMR plus.

[22]  R. Jamal,et al.  Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[23]  Y. Cho,et al.  Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population , 2018, Archives of Osteoporosis.

[24]  A. Munnich,et al.  FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta , 2018, Journal of Medical Genetics.

[25]  A. Verkerk,et al.  Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review , 2018, JBMR plus.

[26]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[27]  A. Tucker,et al.  A review of atypical subtrochanteric femoral fractures in Northern Ireland between 2010 and 2014 , 2018, European Journal of Orthopaedic Surgery & Traumatology.

[28]  P. Fardellone,et al.  Identification of a p.Arg708Gln variant in COL1A2 in atypical femoral fractures. , 2017, Joint, bone, spine : revue du rhumatisme.

[29]  M. Aracena,et al.  Proximal Deletion of 6q Overlapping with Toriello-Carey Facial Phenotype: Prenatal Findings, Clinical Course, Differential Diagnosis, and Review , 2017, Molecular Syndromology.

[30]  D. Lorich,et al.  Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance , 2017, Proceedings of the National Academy of Sciences.

[31]  J. Abril,et al.  GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates. , 2017, The New England journal of medicine.

[32]  M. Yamazaki,et al.  Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases , 2017, Journal of Bone and Mineral Metabolism.

[33]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[34]  M. Zillikens,et al.  Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation. , 2016, Bone.

[35]  E. Remmers,et al.  Hypophosphatasia and the risk of atypical femur fractures: a case–control study , 2016, BMC Musculoskeletal Disorders.

[36]  S. Davis,et al.  Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis. , 2016, Bone.

[37]  S. Khosla,et al.  A Crisis in the Treatment of Osteoporosis , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[39]  Smita Jha,et al.  Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996–2012: An Ecological Analysis , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  J. Millán,et al.  Alkaline Phosphatase and Hypophosphatasia , 2015, Calcified Tissue International.

[41]  M. Brandi,et al.  Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets. , 2015, Bone.

[42]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[43]  C. Boerkoel,et al.  Congenital Bilateral Retinal Detachment in Two Siblings with Osteoporosis-Pseudoglioma Syndrome , 2015, Ophthalmic genetics.

[44]  R. Gibbs,et al.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.

[45]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[46]  Avni Santani,et al.  Actionable exomic incidental findings in 6503 participants: challenges of variant classification , 2015, Genome research.

[47]  R. Visvanathan,et al.  Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: A systematic review , 2015, The journal of nutrition, health & aging.

[48]  N. Nagura,et al.  The incidence of and risk factors for developing atypical femoral fractures in Japan , 2015, Journal of Bone and Mineral Metabolism.

[49]  A. De Paepe,et al.  Type I Procollagen C‐Propeptide Defects: Study of Genotype–Phenotype Correlation and Predictive Role of Crystal Structure , 2014, Human mutation.

[50]  D. Sillence,et al.  Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment , 2014, American journal of medical genetics. Part A.

[51]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[52]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[53]  Thomas D Brown,et al.  Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  M. Brown,et al.  Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome. , 2013, BoneKEy reports.

[55]  Kanako Tachikawa,et al.  A case of autosomal dominant osteopetrosis type II with a novel TCIRG1 gene mutation , 2013, Journal of pediatric endocrinology & metabolism : JPEM.

[56]  Tom R. Gaunt,et al.  Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models , 2012, Human mutation.

[57]  Z. Tümer,et al.  De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature. , 2012, European journal of medical genetics.

[58]  D. Lorich,et al.  Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[60]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[61]  K. Jepsen,et al.  Type XII collagen regulates osteoblast polarity and communication during bone formation , 2011, The Journal of cell biology.

[62]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[63]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[64]  B. Menten,et al.  Developmental delay and connective tissue disorder in four patients sharing a common microdeletion at 6q13-14 , 2010, Journal of Medical Genetics.

[65]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[66]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[67]  O. Mäkitie,et al.  Heterozygous Mutations in the LDL Receptor‐Related Protein 5 (LRP5) Gene Are Associated With Primary Osteoporosis in Children , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  J. Zerwekh,et al.  Severely suppressed bone turnover: a potential complication of alendronate therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[69]  I. Kaitila,et al.  Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients , 2004, Human mutation.

[70]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[71]  A. Villa,et al.  The mutational spectrum of human malignant autosomal recessive osteopetrosis. , 2001, Human molecular genetics.

[72]  A. Chudley,et al.  Proximal interstitial 6q deletion: a recognizable syndrome. , 1997, American journal of medical genetics.